5-10
2026
影响因子区间
109天
平台估算
14%
2025
中国作者发文占比
—
收费
期刊简介:Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs-Muscle-immune interactions during inflammation [...]
【译文】炎症药理学是国际基础与临床药理学联合会(IUPHAR)胃肠分会和匈牙利实验与临床药理学学会(HECPS)的官方出版物。炎症药理学发表关于炎症及其药理控制的各个方面的研究论文,强调不同炎症状态之间的比较,以及用于治疗炎症状态药物的药效、疗效和安全性。炎症状态类型的比较方面包括胃肠道疾病(例如溃疡性结肠炎、克罗恩病)、寄生虫病、药物和环境因素的毒理学表现、关节炎状况以及损伤或衰老对骨骼肌的炎症作用。该杂志有七个主要兴趣领域:药物-疾病相互作用、条件药理学(即条件或应激状态影响治疗反应和抗炎药物的副作用)、药物-疾病相互作用机制和不同应激状态的作用、风湿病学(特别强调新药临床反应效果测量方法、抗风湿药物的副作用)、胃肠病学(特别强调动物和人类模型、粘膜炎症和溃疡的机制以及新型和已建立的抗溃疡、抗炎或抗寄生虫药物的效果)、神经炎症和疼痛(模型系统、新型镇痛剂的药理学和神经炎症、疼痛的机制)、新型药物、天然产物和营养补充剂及其对炎症过程的影响,特别是与常规药物(如NSAIDs)相比有新作用模式的指示,以及炎症期间肌肉-免疫相互作用 [...]

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 2区 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |